Masters of Business Administration - Biopharmaceutical Commercialization in Philadelphia United States | Thomas Jefferson University

Thomas Jefferson University's Master of Business Administration (MBA) program equips students for professional achievement. This MBA delivers a cutting-edge business education tailored to develop future leaders. We foster inclusivity by encouraging students from diverse fields and backgrounds to work together in collaborative teams. Our distinctive program focuses on design thinking, prioritizing exploration, understanding, and innovation. Learners tackle intricate business challenges by crafting original, practical solutions that draw upon their classmates' diverse viewpoints and expertise.
STEM certification enables international F-1 visa holders to qualify for 24 additional months of U.S. work authorization following their initial 12-month OPT period, provided they meet specific requirements.
The Thomas Jefferson University MBA program prioritizes hands-on abilities, analytical decision-making, and leadership growth to prepare graduates for today's demanding employment landscape. Combining challenging academics, real-world experiences, and professional connections, our MBA alumni are prepared to create significant impact across various sectors and leadership positions.
The Biopharmaceutical Commercialization specialization prepares students for successful careers in the biopharma sector, concentrating on bringing advanced therapies like gene treatments, cell therapies, recombinant vaccines, and monoclonal antibodies to market. Students also explore biopharmaceutical manufacturing processes, regulatory standards, quality control measures, and essential marketing approaches and data analysis techniques.